Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Zinc finger protein
ZNF503
is an important regulator during developmental process and tumor initiation.
ZNF503
drives tumor development and process and was cancer-specific dysregulated in cancers. However, its expression and function in
hepatocellular carcinoma
(
HCC
) still need to be studied and elucidated. In this study, we demonstrated for the first time that
ZNF503
mRNA and protein was up-regulated in
HCC
tissues and cell lines. Clinical data showed that high
ZNF503
was significantly correlated with poor prognostic features, including advanced TNM stage and venous invasion. Moreover,
ZNF503
was identified as a potential 5-year prognostic marker of
HCC
patients. Notably,
ZNF503
promoted migration, invasion and EMT progress.
ZNF503
was recruited to GATA3 promoter and inhibited its expression. GATA3 inhibited
HCC
cells migration, invasion and EMT process. Furthermore, we demonstrated that
ZNF503
expression was regulated by miR-495. In
HCC
tissues. MiR-495 has an inverse correlation with
ZNF503
expression. Conclusively, our data revealed that
ZNF503
promoted migration, invasion and EMT process through regulating GATA3 expression, which was regulated by miR-495, suggesting the potential therapeutic value for
HCC
.
...
PMID:ZNF503 accelerates aggressiveness of hepatocellular carcinoma cells by down-regulation of GATA3 expression and regulated by microRNA-495. 3131 55